A phase 2 study of poziotinib in patients with EGFR or HER2 exon 20 mutation-positive non-small cell lung cancer Meeting Abstract

Industry Collaboration

cited authors

  • Yang, Zandong; Tchekmedyian, Nishan; Chu, David T.; Reddy, Guru; Bhat, Gajanan; Socinski, Mark A.

authors

Publication Date

  • May 20, 2018

webpage

published in

category

volume

  • 36

issue

  • 15